CWM
BMY icon

Centric Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Centric Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$23K – 159
2021
Q1 		$23K Buy
+5,000
New +$311K 0.01% 207

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centric Wealth Management's BMY Position: Q3 2024 in Review

Centric Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 4,089 shares — an estimated $206K sold.

Centric Wealth Management first reported a position in BMY in Q3 2019 and held it in 8 quarters. The position peaked at $3.06M in Q1 2021. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Centric Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Centric Wealth Management sold 4,089 Bristol-Myers Squibb shares in Q3 2024, an estimated $206K.
  • Centric Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 8 quarters.
  • Centric Wealth Management's Bristol-Myers Squibb position peaked at $3.06M in Q1 2021.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Centric Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.